YEF3 Antibody

What is YEF3 and why is it significant in research?

YEF3 is an essential gene in Saccharomyces cerevisiae that encodes the eukaryotic elongation factor 3 (eEF3), a critical component of the fungal translation machinery not found in animals or plants . This factor plays multiple crucial roles in translation elongation, including promoting the binding of the ternary complex (acylated-tRNA—eEF1A—GTP) to the ribosomal A-site, facilitating the release of uncharged tRNAs after peptide translocation, and participating in ribosome recycling . The significance of YEF3 in research stems from its uniqueness to fungi, some algae, and select protists, making it an excellent candidate for studying fungal-specific translation mechanisms and potential antifungal therapeutic targets . YEF3 has been shown to be essential in pathogenic fungi such as Candida glabrata, suggesting its potential as a target to combat fungal infections like candidiasis .

How does eEF3 function in the translation elongation process?

eEF3 participates in multiple steps of the translation elongation cycle in fungi. During elongation, eEF3 facilitates three primary functions: First, it promotes the ATP-dependent release of deacylated tRNAs from the ribosomal E-site after peptide translocation . Second, it stimulates the eEF1A-dependent binding of aminoacyl-tRNA to the ribosomal A-site, which has reduced affinity for tRNA as long as the E-site is occupied . Third, it plays a crucial role in the recycling process by promoting the disassembly of post-termination complexes into their components . Mechanistically, eEF3 functions as an ATP-binding cassette (ABC) ATPase, with its ATPase activity being essential for its function in translation . This complex interplay between eEF3 and other translation factors contributes to the unique characteristics of fungal protein synthesis mechanisms compared to those in other eukaryotes.

What is the relationship between YEF3 and its paralog HEF3?

YEF3 and HEF3 are paralogous genes in Saccharomyces cerevisiae that encode highly similar proteins (84% sequence identity), but they exhibit distinct functional roles in cellular physiology . While YEF3 is essential for yeast viability and cannot be deleted, HEF3 is non-essential under standard growth conditions . The HEF3 gene likely arose from an ancient whole-genome duplication event in yeast evolutionary history . Despite their sequence similarity, these paralogs show functional divergence: Yef3p demonstrates approximately two-fold higher ribosome-dependent ATPase activity than Hef3p, though they exhibit similar basal ATPase activity and ribosome affinity . Significantly, research has demonstrated that HEF3 plays a specific role in oxidative stress response, with HEF3-deleted cells showing increased sensitivity to hydrogen peroxide, particularly at higher concentrations and temperatures . This functional specialization appears to be linked to Hef3p's involvement in regulating the expression of enzymes important for reactive oxygen species (ROS) detoxification, including superoxide dismutase 2 (Sod2p) .

How conserved is eEF3 function across different fungal species?

Recent research demonstrates partial conservation of eEF3 function across phylogenetically distant fungi, though with notable variability . Functional conservation studies using in vivo genetic approaches have shown that eEF3 proteins from Zygosaccharomyces rouxii and Candida glabrata (phylum Ascomycota), Ustilago maydis (phylum Basidiomycota), and Gonapodya prolifera (phylum Monoblepharomycota) can support the growth of S. cerevisiae lacking the endogenous YEF3 gene . Interestingly, eEF3 from Aspergillus nidulans (phylum Ascomycota) failed to complement YEF3 function in S. cerevisiae despite belonging to the same phylum as two complementing species . This suggests that functional conservation of eEF3 does not strictly follow phylogenetic relationships. The essentiality of eEF3 has been confirmed in pathogenic fungi like C. glabrata and the filamentous fungus A. nidulans, indicating conservation of its critical role in translation across diverse fungal lineages . This variable pattern of functional conservation reveals the evolutionary plasticity of translation machinery across the fungal kingdom and highlights the importance of experimental validation beyond in silico predictions of ortholog function.

What methodological approaches can be used to study eEF3 function in non-model fungal species?

Investigating eEF3 function in non-model fungi requires a multi-faceted experimental strategy combining genetic, biochemical, and structural approaches. One effective genetic approach involves complementation assays, where the eEF3 gene from the target fungal species is expressed in S. cerevisiae strains with their endogenous YEF3 deleted . This methodology requires creating yeast strains where the chromosomal YEF3 is replaced with a selectable marker (e.g., KANMX conferring kanamycin resistance) while maintaining viability through a plasmid-borne copy of YEF3 that can be counterselected . The target fungal eEF3 gene can be obtained either through PCR amplification from genomic DNA (as done for Z. rouxii, C. glabrata, and U. maydis) or through in vitro synthesis with codon optimization for expression in S. cerevisiae (as used for G. prolifera and A. nidulans) .

For biochemical characterization, recombinant expression and purification of tagged eEF3 proteins (e.g., with HA or His tags) allows comparative analysis of their ribosome-binding properties and ATPase activities . The essential nature of eEF3 in various fungi can be tested through gene deletion strategies using appropriate selectable markers, with conditional promoters to control expression when the gene proves essential . Structural studies might employ cryo-electron microscopy to visualize eEF3-ribosome interactions across species. Additionally, specific antibodies against eEF3, such as the rabbit polyclonal anti-eEF3 antibody, can be valuable tools for detection and quantification of the protein in different fungal species using western blotting techniques .

What is the potential of eEF3 as an antifungal drug target, and how can this be experimentally evaluated?

eEF3 represents a promising antifungal drug target due to several key characteristics: it is essential in pathogenic fungi including Candida glabrata, it is absent in humans and other mammals, and it plays a crucial role in fungal-specific translation mechanisms . The experimental evaluation of eEF3 as a drug target requires a systematic approach combining structural, biochemical, and in vivo studies.

The first step would involve high-resolution structural characterization of eEF3 proteins from pathogenic fungi to identify potential druggable pockets, particularly focusing on the ATP-binding cassette domains that are critical for function . This structural information could guide in silico screening of compound libraries to identify potential inhibitors. Candidate compounds would then be evaluated through biochemical assays measuring their ability to inhibit eEF3's ATPase activity and its interaction with ribosomes.

Promising inhibitors could be further tested in cellular assays using both pathogenic fungi and mammalian cells to establish their selective toxicity. Genetic approaches can provide complementary evidence: constructing strains with reduced eEF3 expression or activity-compromised eEF3 mutants would help validate whether partial inhibition is sufficient for antifungal effects . Additionally, resistance development studies would assess the potential longevity of any eEF3-targeting drugs.

Finally, animal models of fungal infection would be necessary to evaluate the efficacy and safety of lead compounds in vivo. The recent demonstration that eEF3 is essential in the opportunistic pathogen C. glabrata strengthens the rationale for pursuing this target to combat candidiasis and potentially other fungal infections .

What are the optimal protocols for using anti-eEF3 antibodies in Western blotting experiments?

For optimal Western blotting results with anti-eEF3 antibodies, researchers should follow a carefully optimized protocol tailored to the characteristics of this antibody. Based on the commercially available rabbit polyclonal anti-eEF3 antibody, the following methodology is recommended:

• Sample Preparation: Extract total proteins from fungal samples using a method that preserves protein integrity, such as mechanical disruption with glass beads in a suitable lysis buffer containing protease inhibitors. Quantify protein concentration using Bradford or BCA assays.

• Gel Electrophoresis: Load 10-30 μg of total protein per lane on an 8% SDS-PAGE gel (optimal for resolving the 116 kDa eEF3 protein) . Include molecular weight markers spanning the 100-130 kDa range.

• Transfer: Transfer proteins to a PVDF membrane using a semi-dry or wet transfer system (25V for 1.5 hours or 100V for 1 hour, respectively).

• Blocking: Block the membrane with 5% non-fat dry milk in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature.

• Primary Antibody: Dilute the reconstituted anti-eEF3 antibody 1:10,000 in blocking solution . Incubate the membrane overnight at 4°C with gentle agitation.

• Washing: Wash the membrane 3 times for 10 minutes each with TBST.

• Secondary Antibody: Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5,000-1:10,000) for 1 hour at room temperature.

• Detection: After washing, develop the signal using enhanced chemiluminescence (ECL) reagent and image using an appropriate detection system.

• Controls: Include a positive control (S. cerevisiae wild-type extract) and potentially a negative control (extract from a non-fungal organism) .

When optimizing this protocol, pay special attention to the reconstitution step for the antibody, as it comes lyophilized and should be reconstituted in 25 μL of water . For quantitative analyses, consider using loading controls such as GAPDH or β-actin, though these may require separate blotting due to the size difference from eEF3.

How can researchers generate and validate knockout or conditional mutants of YEF3 for functional studies?

Generating YEF3 mutants requires careful strategic planning due to its essential nature in many fungi. The following methodological approach is recommended:

For Knockout Mutants in Haploid Organisms:

• Plasmid Rescue Strategy: First, transform cells with a plasmid containing wild-type YEF3 and a selectable marker (e.g., URA3) . Next, delete the chromosomal YEF3 gene using homologous recombination with a disruption cassette containing a different selectable marker (e.g., KANMX conferring kanamycin resistance) . The resulting strain will rely on the plasmid-borne YEF3 for survival.

• Disruption Cassette Construction: Create a cassette containing a selectable marker (e.g., KANMX or NATMX) flanked by 500-1000 bp sequences homologous to the regions upstream and downstream of the YEF3 coding sequence . PCR can be used to generate this construct with appropriate primers.

• Transformation and Selection: Transform yeast cells using lithium acetate or electroporation methods and select transformants on appropriate media containing antibiotics .

For Conditional Mutants:

• Promoter Replacement: Replace the native YEF3 promoter with a regulatable promoter such as GAL1 (galactose-inducible/glucose-repressible) or tetO (tetracycline-responsive) using homologous recombination .

• Temperature-Sensitive Mutants: Generate random or site-directed mutations in YEF3 and screen for clones that show normal growth at permissive temperatures but defective growth at restrictive temperatures.

Validation Methods:

• PCR Verification: Confirm correct integration of disruption cassettes or promoter replacements using primers that span the junctions between inserted DNA and genomic sequences .

• Western Blotting: Verify protein depletion in conditional mutants using anti-eEF3 antibodies at various time points after promoter repression .

• Growth Assays: Document growth phenotypes under various conditions (temperature, carbon source, stress) using serial dilution spot tests on solid media or growth curves in liquid media .

• Complementation Tests: Test whether mutant phenotypes can be rescued by reintroduction of wild-type YEF3 or by orthologs from other species to assess functional conservation .

• Polysome Profiling: Analyze polysome profiles to assess the impact of YEF3 depletion on global translation.

This methodical approach allows for rigorous functional characterization while accounting for the essential nature of YEF3 in most fungal systems.

What approaches can be used to investigate the differential roles of YEF3 and HEF3 in fungal stress responses?

Investigating the distinct roles of YEF3 and HEF3 in stress responses requires integrating genetic, biochemical, and genomic approaches. The following methodological strategy would enable comprehensive analysis:

Genetic Approaches:

• Strain Construction: Generate single deletion mutants (hef3Δ), conditional YEF3 mutants (e.g., with tetracycline-repressible promoters), and strains with altered expression levels (overexpression constructs) . For double mutant analysis, create strains where HEF3 is deleted and YEF3 is under conditional control.

• Stress Response Assays: Expose these strains to various stressors including oxidative agents (H₂O₂, menadione), heat shock, osmotic stress, and nutrient limitation . Perform quantitative growth assays using serial dilutions on solid media with different stressor concentrations or growth curve analysis in liquid media .

• Genetic Interaction Analysis: Combine YEF3/HEF3 mutations with deletions of known stress response regulators (e.g., in the Hog1 pathway) to identify epistatic relationships.

Molecular and Biochemical Approaches:

• Protein Expression Analysis: Use Western blotting with anti-eEF3 antibodies to monitor Yef3p and Hef3p levels under different stress conditions . Epitope tagging (e.g., HA-tag) can help distinguish between the paralogs .

• Ribosome Association Studies: Perform polysome fractionation followed by Western blotting to determine if the ribosome association of Yef3p and Hef3p changes under stress conditions .

• ATPase Activity Assays: Compare the ATPase activity of purified Yef3p and Hef3p under normal and stress-mimicking conditions (e.g., varying pH, salt concentrations) .

Genomic and Proteomic Approaches:

• Transcriptome Analysis: Perform RNA-Seq on wild-type, hef3Δ, and YEF3-depleted cells under normal and stress conditions to identify differentially expressed genes .

• Translatome Analysis: Use ribosome profiling to identify specific mRNAs whose translation is affected by absence of HEF3 or depletion of YEF3 during stress responses .

• Proteome Analysis: Employ quantitative proteomics (e.g., SILAC or TMT labeling) to identify proteins whose levels change in mutant strains, with particular focus on stress response proteins like Sod2p .

A particularly revealing experiment would be to perform oxidative stress assays (e.g., H₂O₂ exposure at 0.5-1.5 mM) with wild-type cells, hef3Δ cells, and hef3Δ cells complemented with either HEF3 or YEF3 under a strong promoter . This would determine whether YEF3 overexpression can compensate for HEF3 loss during oxidative stress, providing insight into their functional overlap and specificity.

How can researchers effectively study eEF3-ribosome interactions at the molecular level?

Investigating eEF3-ribosome interactions at the molecular level requires a multi-technique approach combining structural, biochemical, and biophysical methods. The following methodological framework is recommended:

• Cryo-Electron Microscopy (Cryo-EM): This technique provides high-resolution structural insights into eEF3-ribosome complexes. Sample preparation should include purified ribosomes from the fungal species of interest, recombinant eEF3 (potentially with affinity tags for purification), and nucleotides (ATP or non-hydrolyzable analogs) . Verify complex formation before vitrification using biochemical assays such as co-sedimentation. Process the resulting images using single-particle analysis to reconstruct 3D structures of the complexes in different functional states.

• Ribosome Binding Assays: Quantify the interaction between eEF3 and ribosomes using purified components. Filter binding assays or surface plasmon resonance (SPR) can determine binding affinities (Kd values) and kinetic parameters (kon and koff) for wild-type eEF3 and structure-based mutants . Compare the binding properties of Yef3p and Hef3p under various conditions to understand their functional differences .

• Cross-linking Mass Spectrometry (XL-MS): This approach identifies specific contact points between eEF3 and ribosomal components. Perform chemical cross-linking of eEF3-ribosome complexes using reagents like BS3 or DSS, followed by protease digestion and LC-MS/MS analysis to identify cross-linked peptides . The resulting data can map the interaction interface at amino acid resolution.

• Site-directed Mutagenesis: Generate targeted mutations in domains of eEF3 predicted to interact with the ribosome based on structural data . Express these mutants, purify them, and test their ribosome binding and functional activity in biochemical assays. This approach can validate and functionally characterize specific interaction sites.

• Fluorescence-based Assays: Employ fluorescently labeled eEF3 (using site-specific labeling techniques) and FRET (Förster Resonance Energy Transfer) or fluorescence anisotropy to monitor binding dynamics and conformational changes during the interaction with ribosomes in real-time .

• ATPase Activity Assays: Measure the ribosome-stimulated ATPase activity of eEF3 using colorimetric assays (e.g., malachite green) or radio-labeled ATP . Compare the activities of eEF3 from different fungal species or mutant variants to correlate structural features with enzymatic function .

These complementary approaches provide a comprehensive understanding of the molecular details of eEF3-ribosome interactions, which is essential for developing targeted antifungal strategies and understanding the unique aspects of fungal translation.

What experimental design considerations are important when comparing YEF3 function across diverse fungal species?

When designing experiments to compare YEF3 function across fungal species, researchers should address several key methodological considerations to ensure valid comparative analyses:

• Sequence and Structural Analysis Prerequisites:

  • Perform comprehensive phylogenetic analysis of eEF3 sequences across target fungal species to establish evolutionary relationships .

  • Analyze sequence conservation in functional domains (ABC ATPase domains, ribosome-binding regions) to predict functional similarity .

  • Use homology modeling to predict structural differences that might impact function in the absence of crystal structures.

• Expression System Selection:

  • Choose between heterologous expression in S. cerevisiae (for complementation studies) or native expression systems .

  • When using S. cerevisiae, consider whether to use the native YEF3 promoter or constitute strong promoters to normalize expression levels .

  • For heterologous expression, decide whether to use the native sequence or codon-optimized versions for the expression host .

• Functional Complementation Design:

  • Create standardized yeast strains with genomic YEF3 deleted and maintained by a counterselectable plasmid (e.g., URA3-based pVT-U-YEF3) .

  • Express eEF3 from different fungal species using identical vectors and promoters to ensure comparable expression levels .

  • Include appropriate epitope tags (e.g., HA tag) to monitor protein expression and stability across different constructs .

  • Establish quantitative metrics for complementation such as growth rate measurement rather than simple growth/no growth observations.

• Protein Expression Verification:

  • Confirm expression of heterologous eEF3 proteins using Western blotting with anti-eEF3 antibodies or epitope-tag antibodies .

  • Quantify expression levels to ensure differences in complementation are not due to protein abundance variations.

  • Assess protein stability and half-life to account for potential degradation of heterologous proteins.

• Phenotypic Analysis Parameters:

  • Test complementation under various growth conditions (temperature, carbon source, stress conditions) to identify condition-specific functional differences .

  • Measure growth parameters quantitatively using growth curves in liquid media in addition to spot assays on solid media .

  • Analyze polysome profiles to assess translation efficiency in strains expressing different eEF3 orthologs.

• Domain Swap Experiments:

  • Design chimeric constructs exchanging domains between complementing and non-complementing eEF3 proteins to identify critical regions for species-specific function .

  • Create point mutations in conserved residues that differ between species to pinpoint specific amino acids responsible for functional differences.

• Controls and Validation:

  • Include multiple biological and technical replicates to ensure reproducibility.

  • Use positive controls (S. cerevisiae YEF3) and negative controls (empty vector) in all experiments .

  • Validate key findings using independent approaches (e.g., combining in vivo complementation with in vitro biochemical assays).

This methodical approach ensures that observed differences in eEF3 function across fungal species reflect genuine biological variation rather than experimental artifacts, providing insights into the evolution and specialization of translation machinery in fungi.

How might the study of YEF3 inform our understanding of translational control during fungal stress responses?

The study of YEF3 and its paralog HEF3 provides unique insights into how fungi regulate translation during stress responses, particularly oxidative stress. Recent research reveals several important mechanistic connections that can guide future investigations:

Translation elongation represents a critical control point in gene expression regulation during stress. The differential roles of Yef3p and Hef3p suggest a sophisticated mechanism by which fungi can modulate translation of specific mRNAs during stress conditions . While Yef3p functions as the primary elongation factor under normal growth conditions, Hef3p appears specialized for stress conditions, particularly oxidative stress . This functional specialization likely contributes to the selective translation of stress-responsive proteins.

Experimental evidence shows that cells lacking HEF3 (hef3Δ) exhibit increased sensitivity to hydrogen peroxide, especially at higher concentrations (1-1.5 mM) and elevated temperatures . Notably, these cells show reduced expression of superoxide dismutase 2 (Sod2p), a key mitochondrial enzyme involved in ROS detoxification, even under normal growth conditions . This suggests Hef3p specifically promotes the translation of oxidative stress response proteins.

To investigate the mechanisms underlying this translational control, researchers should employ ribosome profiling to identify mRNAs specifically regulated by Yef3p versus Hef3p during oxidative stress . This approach would involve isolating ribosome-protected fragments from wild-type, hef3Δ, and YEF3-depleted cells under normal and oxidative stress conditions, followed by deep sequencing and bioinformatic analysis to identify differentially translated mRNAs. Additionally, studies might examine whether Hef3p associates with specific subpopulations of ribosomes or whether it recognizes particular features in mRNAs encoding stress-response proteins.

The functional divergence between Yef3p and Hef3p, despite their high sequence similarity (84%), exemplifies how gene duplication events can lead to specialization that enhances cellular stress adaptation mechanisms . Understanding this relationship may provide a paradigm for investigating other duplicated components of the translation machinery across fungal species.

What technical challenges exist in developing specific inhibitors targeting eEF3, and how might they be overcome?

Developing specific inhibitors targeting eEF3 presents several technical challenges due to its structural complexity and biochemical properties. A strategic approach to overcome these challenges includes:

Challenge 1: Protein Purification and Stability
eEF3 is a large (116 kDa) multi-domain protein with complex folding requirements . Obtaining sufficient quantities of pure, properly folded, and active protein for screening assays presents significant difficulties.

Solution Approach: Implement expression systems using fungal hosts rather than bacterial systems to ensure proper folding and post-translational modifications. Utilize affinity tags like the 6xHis tag used for antibody generation , combined with size exclusion chromatography for final purification. Stabilize purified protein with optimized buffer conditions including glycerol, reducing agents, and appropriate salt concentrations determined through thermal shift assays.

Challenge 2: Assay Development for High-Throughput Screening
Traditional ATPase assays may not be amenable to high-throughput screening formats, and ribosome-dependent activity requires complex assay components.

Solution Approach: Develop fluorescence-based assays measuring ATP hydrolysis using coupled enzyme systems or fluorescent ATP analogs. Alternatively, design FRET-based assays that detect conformational changes upon inhibitor binding. For initial screening, focus on the intrinsic ATPase activity of eEF3 before advancing to more complex ribosome-dependent assays for validation. Establish robust positive controls using non-hydrolyzable ATP analogs and statistical parameters (Z-factor >0.5) to ensure assay quality.

Challenge 3: Achieving Selectivity Between Fungal Species
While targeting eEF3 offers selectivity against human cells (which lack this protein), achieving specificity between pathogenic and beneficial fungi presents a challenge .

Solution Approach: Perform detailed structural comparisons of eEF3 from various fungal species, focusing on pathogen-specific features . Utilize the functional complementation data showing that eEF3 from different fungi varies in its ability to replace S. cerevisiae Yef3p . This suggests structural or functional differences that could be exploited for selective inhibition. Structure-based design approaches should target regulatory regions or interfaces specific to pathogenic fungi rather than the highly conserved catalytic core.

Challenge 4: Cellular Penetration of Inhibitors
Fungal cell walls present a significant barrier to drug entry, particularly for compounds targeting intracellular proteins.

Solution Approach: Incorporate medicinal chemistry strategies to enhance compound permeability across fungal membranes, such as adding lipophilic groups or designing prodrug approaches. Screen compound libraries enriched for molecules with established antifungal activity. Consider combination approaches with compounds that increase cell wall permeability.

Challenge 5: Validation of Target Engagement
Confirming that observed antifungal effects result from specific eEF3 inhibition rather than off-target effects presents technical difficulties.

Solution Approach: Develop cellular thermal shift assays (CETSA) to measure target engagement in intact cells. Generate eEF3 variants with reduced inhibitor binding but maintained function to serve as controls. Perform transcriptomic and proteomic profiling to confirm that inhibitor treatment produces signatures consistent with eEF3 inhibition rather than other cellular targets.

By systematically addressing these challenges, researchers can develop eEF3 inhibitors with potential as novel antifungal therapeutics, particularly valuable given the essential nature of eEF3 in pathogenic fungi like Candida glabrata .